Hansol Holdings (KRX 004150) 2026 stock outlook for US investors: the NAV discount on its paper, chemicals, electronics and logistics stakes, whether the logistics and paper upswing lasts, dividends, value-up reform, and quarterly checks.
Noroo Holdings (KRX 000320) stock outlook for 2026: how the paint and ink holding structure around Noroo Paint works, why it trades at a low price-to-book, construction and raw-material risks, the holding discount, and practical scenarios for US investors.
Maeil Holdings (005990) 2026 outlook for foreign investors: how the holdco owns Maeil Dairies (267980), equity-method income, low P/E and P/B, raw milk costs, falling births, holdco discount, plus KR market access and FX.
HDC Corp (KRX 012630, formerly Hyundai Development Company) 2026 stock outlook: how the holding company controls HDC Hyundai Development and Icontrols, construction-cycle leverage, the holdco discount, risks, peers, and how foreigners access the stock.
Solbrain Holdings (036830, formerly Soulbrain) 2026 stock outlook: semiconductor etchant and EV battery electrolyte exposure through subsidiary Soulbrain (357780), the holding-company discount, and how foreign investors can access it.
Hyundai G.F. Holdings (005440, formerly Hyundai Green Food) 2026 outlook: Hyundai Department Store Group's pure holding company, stakes in retail, home shopping and fashion, dividend growth, the holdco discount, and how foreign investors handle KRX access, tax and won exposure.
Crown Haitai Holdings (005740) 2026 stock analysis: the confectionery holding company behind Crown Confectionery and Haitai Confectionery, its cocoa-sugar-wheat inflation exposure, pricing power on legacy snack brands, and the structural holdco discount weighing on the shares.
Wonik Holdings (KRX 030530) 2026 stock analysis: sum-of-the-parts NAV versus the market's holding-company discount on Wonik IPS and Wonik QnC stakes, the specialty gas business, semiconductor capex cycle exposure, and founder-family governance.
Easy Holdings (KRX 035810, formerly Easybio) 2026 stock outlook: the holding company distinct from operating firm Easybio (353810), its feed-hog-meat chain via Manikorea and Woorison, grain-cost FX exposure, and the domestic Korean tax rules that apply.
Daesung Holdings (016710) stock outlook for 2026, covering its city gas revenue base, Korea's cost-of-service tariff and LNG pass-through mechanism, dividend appeal versus holding-company discount, renewable expansion optionality, and the practical access and tax hurdles a US-based investor faces buying a KRX-listed utility holding company.
Hite Jinro Holdings (000140) 2026 stock analysis for US investors: how this Korean holding company controls operating unit Hite Jinro (000080), the soju and beer brands behind it, the holdco discount, dividend and royalty cash flows, owner-family governance, and Korea dividend withholding tax.
Daou Data (032190) 2026 stock outlook. A qualitative deep dive into the KOSDAQ-listed top holding company of the Daou-Kiwoom group: its double holding structure over Kiwoom Securities, the persistent NAV discount, its IT distribution and VAN/PG payments business, capital allocation, and governance catalysts.
Poongsan Holdings (005810) 2026 stock outlook. A deep qualitative look at the operating-holding-company structure and its ~35% stake in Poongsan (103140), the defense ammunition super-cycle, copper and non-ferrous metal exposure, the NAV holding-company discount, and how US investors should think about tax, FX, and what to watch each quarter.
SeAH Steel Holdings (KOSPI 003030) stock outlook for 2026: US OCTG pipe demand and tariff protection, the new offshore wind monopile and jacket business, the holding-company NAV discount, how 003030 differs from operating unit SeAH Steel (306200), and peer comparisons against Husteel, NEXTEEL and Dongkuk Steel.
KPX Holdings (092230) 2026 stock outlook. A qualitative deep dive into the KPX Chemical polyol and polyurethane cycle, the persistent Korean holding-company NAV discount, net-cash and dividend durability, value-up catalysts, and the cyclical risks a US investor faces.
AJ Networks (095570) stock outlook for 2026, covering the pallet, construction-equipment, and IT-device operating-lease spread model, interest-rate and utilization sensitivity, leverage and coverage ratios, and the holding-company discount versus subsidiary asset value.
Harim Holdings (003380) stock outlook 2026: a deep, qualitative look at the Korean agri-food holding company sitting on top of poultry maker Harim, feed operations, and bulk shipper Pan Ocean, covering NAV-versus-market-cap holding discount mechanics, grain and feed-margin cycles, chicken price pass-through, and the long-running Yangjae land redevelopment option.
DL (000210) DL Holdings (formerly Daelim Industrial) 2026 stock outlook. A qualitative deep dive into the net-asset-value holding-company discount, the DL E&C and DL Chemical subsidiary earnings link, dividend, trademark-royalty and rental income, and shareholder returns for foreign investors.
Cosmax BTI (044820) 2026 stock outlook. A deep look at the Cosmax Group holding company: how its stake in listed operating unit Cosmax (192820) and health-supplement maker Cosmax NBT drives net-asset value, why holdco discounts persist, dividend flow, dual-listing risk, and how it differs from the operating company itself.
SGC Energy (KRX: 005090) 2026 stock outlook. A qualitative deep-dive into its Gunsan district-energy cogeneration and power sales, solar and renewables option, the fuel-cost spread that drives quarterly margins, and the SGC Group holding-company character (SGC E&C construction and SGC Solution glass) that makes it a low price-to-book asset play with real discounts attached.
PSK Holdings (031980) 2026 stock outlook. A Korean holding company whose value rests on its controlling stake in PSK Inc (319660), the dry-strip and photoresist-removal front-end equipment maker, leveraged to the memory capex cycle and HBM etch demand but weighed down by a persistent parent-subsidiary holding discount, analyzed qualitatively for US investors.
JW Holdings (096760) 2026 stock outlook. A deep qualitative look at Korea's IV-fluid oligopoly moat, JW Life Science and JW Bioscience subsidiary leverage, the gout and oncology pipeline, holding-company NAV discount, and drug-pricing risk for the JW Pharmaceutical group.
Huons Global (084110) stock outlook for 2026. A deep qualitative look at this Korean pharma holding company behind Huons and Humedix: eye-drop cash cow, aesthetics and HA fillers, botulinum toxin exports, China and Brazil regulatory catalysts, dividend appeal, and the persistent holding-company discount.
Nongshim Holdings (072710) 2026 stock outlook. A holding-company view of the Nongshim Group structure, the persistent holdco discount, subsidiary Nongshim's (004370) Shin Ramyun US factory expansion, dividend flow tied to subsidiary earnings, and wheat and palm-oil input-cost cycles.